Maki, S.; Tanaka, H.; Tsuji, M.; Furuhashi, F.; Magawa, S.; Kaneda, M.K.; Nii, M.; Tanaka, K.; Kondo, E.; Tamaru, S.;
et al. Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial. J. Clin. Med. 2019, 8, 856.
https://doi.org/10.3390/jcm8060856
AMA Style
Maki S, Tanaka H, Tsuji M, Furuhashi F, Magawa S, Kaneda MK, Nii M, Tanaka K, Kondo E, Tamaru S,
et al. Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial. Journal of Clinical Medicine. 2019; 8(6):856.
https://doi.org/10.3390/jcm8060856
Chicago/Turabian Style
Maki, Shintaro, Hiroaki Tanaka, Makoto Tsuji, Fumi Furuhashi, Shoichi Magawa, Michiko K. Kaneda, Masafumi Nii, Kayo Tanaka, Eiji Kondo, Satoshi Tamaru,
and et al. 2019. "Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial" Journal of Clinical Medicine 8, no. 6: 856.
https://doi.org/10.3390/jcm8060856
APA Style
Maki, S., Tanaka, H., Tsuji, M., Furuhashi, F., Magawa, S., Kaneda, M. K., Nii, M., Tanaka, K., Kondo, E., Tamaru, S., Ogura, T., Nishimura, Y., Endoh, M., Kimura, T., Kotani, T., Sekizawa, A., & Ikeda, T.
(2019). Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial. Journal of Clinical Medicine, 8(6), 856.
https://doi.org/10.3390/jcm8060856